跳至主要内容
临床试验/NCT06572410
NCT06572410招募中不适用

Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision

Elucent Medical1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年8月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Margin Positivity

研究概览

简要总结

Observational study. The purpose of this study is to evaluate the use of real-time surgical navigation for the localization and surgical removal of soft tissue tumors. The goal is to collect information about the efficiency and effectiveness of the EnVisio Surgical Navigation for intraoperative guidance to obtain negative margin on initial specimen.

Prospective Patient Study: 200 consecutive patients

详细描述

Objectives

1.) To collect data throughout clinical patient workflow for evaluation of.

  1. localization with SmartClip(s)
  2. negative margin on primary specimen
  3. specimen assessment
  4. length of operation

The EnVisio® Navigation System was cleared as a Class II device by the FDA under 510(k) number K183400. The SmartClip® Soft Tissue Marker was cleared by the FDA under 510(k) number K180640.

Principal Investigator will receive monthly EnVisio system data from Company representative on the EnVisio system data collection for procedural cross reference resulting in.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient has image identifiable lesion.
  • Patient has selected breast conservation therapy IE: lumpectomy +/-radiation therapy, +/- chemotherapy +/- hormonal or targeted therapies. Neoadjuvant chemotherapy is not an exclusion criterion.
  • Patient will be undergoing target tissue localization with the SmartClip
  • Patient will be undergoing BCS Breast Conserving Surgery treatment for DCIS or invasive breast cancer with EnVisio ® Navigation System.
  • Patient must be age > or = 18 years.
  • Patients unable to provide consent to surgery must have authorized representative provide consent.

排除标准

  • Patients undergoing mastectomy for resection of the targeted lesion.
  • Patient is localized with an alternative method.
  • Patient that are pregnant.

结局指标

主要结局

Margin Positivity

时间窗: Day of Surgery

Specimen surgical resection volume gross measurements in 3 dimensions (length, width, depth) day of surgery. Definitive gross pathology results on final margin

次要结局

未报告次要终点

研究者

发起方
Elucent Medical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验